Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Orchid Pharma Limited ( (IN:ORCHPHARMA) ) has issued an update.
Orchid Pharma Limited announced the results of its 32nd Annual General Meeting, which was held virtually on September 20, 2025. The meeting, conducted in compliance with regulatory guidelines, included remote e-voting and e-voting at the AGM. This approach reflects the company’s adaptation to ongoing pandemic-related challenges, ensuring shareholder participation and compliance with corporate governance standards.
More about Orchid Pharma Limited
Orchid Pharma Limited, a Dhanuka Group Company, operates in the pharmaceutical industry, focusing on the development and manufacturing of pharmaceutical products. The company is based in Tamil Nadu, India, and is listed on the National Stock Exchange of India and BSE Limited.
Average Trading Volume: 8,362
Technical Sentiment Signal: Buy
Current Market Cap: 39.99B INR
See more data about ORCHPHARMA stock on TipRanks’ Stock Analysis page.